Open AccessSelpercatinib (Retevmo)
Author(s) -
CADTH
Publication year - 2022
Publication title -
canadian journal of health technologies
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2022.458
Subject(s) - lenvatinib , reimbursement , medicine , sorafenib , drug , thyroid cancer , thyroid carcinoma , oncology , intensive care medicine , family medicine , thyroid , pharmacology , political science , health care , hepatocellular carcinoma , law